EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Fecal calprotectin level in microscopic colitis: a systematic review and meta-analysis

Busara Songtanin iD, Chanaka Kahathuduwa, Kenneth Nugent

Baylor University Medical Center Proceedings · 03.09.2023 · 36 (5) · 641-646

DOI: 10.1080/08998280.2023.2223950 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Baylor University Medical Center Proceedings, online erschienen am 14.06.2023. Verfasst von Busara Songtanin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are no specific biomarkers for microscopic colitis (MC), and the diagnosis depends on histopathological tissue obtained during colonoscopy. Studies on the role of fecal calprotectin (FCP) in MC are limited. A literature search of PubMed, Embase, and Scopus was conducted from each database's inception through September 2022.

Methods

A DerSimonian-Liard random-effects meta-analysis was performed to examine the standardized mean difference (SMD) in FCP levels between patients with MC and control patients with chronic diarrhea.

Results

Six studies with 96 active MC patients and 200 controls were included in the meta-analysis. Random effects meta-analysis revealed that FCP was significantly and moderately elevated in patients with MC compared to the control group (SMD = 0.6 [95% CI 0.3, 1.0], P = 0.001). Imputing one effect size confirmed the observation that FCP is significantly higher in patients with MC than control subjects with chronic diarrhea (SMD = 0.5 [95% CI 0.2, 0.9], P = 0.004). Study heterogeneity between the SMDs was not significant (I2 = 41%, P = 0.1).

Conclusion

These results indicate that FCP levels in patients with chronic diarrhea can help identify patients with MC. More studies with serial measurements of FCP would provide a better understanding of its utility in MC.

Schlagwörter

Stichwörter der Autor:innen

Chronic diarrheacollagenous colitisfecal calprotectinlymphocytic colitismicroscopic colitis

Autor:innen und Institutionen

  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

ORCID-Profile: Busara Songtanin

Zitieren

APA

Songtanin, B., Kahathuduwa, C., & Nugent, K. (2023). Fecal calprotectin level in microscopic colitis: a systematic review and meta-analysis. Baylor University Medical Center Proceedings, 36(5), 641-646. https://doi.org/10.1080/08998280.2023.2223950

Vancouver

Songtanin B, Kahathuduwa C, Nugent K. Fecal calprotectin level in microscopic colitis: a systematic review and meta-analysis. Baylor University Medical Center Proceedings. 2023;36(5):641-646. doi:10.1080/08998280.2023.2223950

BibTeX
@article{Songtanin2023,
  author = {Songtanin, Busara and Kahathuduwa, Chanaka and Nugent, Kenneth},
  title = {Fecal calprotectin level in microscopic colitis: a systematic review and meta-analysis},
  journal = {Baylor University Medical Center Proceedings},
  year = {2023},
  volume = {36},
  number = {5},
  pages = {641--646},
  doi = {10.1080/08998280.2023.2223950}
}
Kostenlos starten →